Pulse Biosciences, Inc.

This early study tests a new device that uses nanosecond electric pulses to treat atrial fibrillation (an irregular heartbeat) during heart surgery. About 30 adults aged 18-85 with a history of atrial fibrillation will receive the treatment. The goal is to see if the device can s…

This study tests a new device that uses short electrical pulses to treat atrial fibrillation (an irregular heartbeat) while people are already having heart surgery for other reasons. About 135 adults aged 18-85 with a history of atrial fibrillation will take part. The goal is to …

This study is testing a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this treatment. The goal is to…

This study tests a new device that uses electrical pulses to shrink benign (non-cancerous) thyroid nodules without surgery. About 100 adults with symptomatic nodules will receive the treatment and be followed for up to a year. The goal is to reduce nodule size and improve symptom…

This study tests a new device that uses quick electrical pulses to fix faulty heart signals in people with paroxysmal atrial fibrillation (a type of irregular heartbeat). About 215 adults who have not gotten better with medication will receive the procedure. The goal is to see if…